Biomarker Technologies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Instruments, Assay and Reagents, and Consumables); Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Immunoassay, and Others); Indication (Cancer, Infectious Diseases, Autoimmune Disorders, Cardiovascular Disorders, and Others); Application (Drug Discovery, Diagnostics, and Personalized Medicine), and Geography

Report Code: TIPRE00003070 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

A biomarker is a biological trait that is examined and assessed as a predictor of normal biological or pathological processes, or a therapeutic response. Gene expression patterns, for example, are used to diagnose a variety of disorders. In a biological system, a biomarker is a measurable sign that is used to indicate exposure, susceptibility, effect, or clinical disease. This technology can be used in observational and analytic epidemiology, screening and diagnosis, randomized clinical trials, and prognosis, among other.

MARKET SCOPE

The "Global Biomarker Technologies Market Analysis to 2028" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of the biomarker technologies market with detailed market segmentation by product, technology, indication, application, and geography. The report provides key statistics on the market status of the leading biomarker technologies market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION

  •   Based on product, the market is bifurcated into instruments, assay and reagents, and consumables
  •   Based on technology, the market is bifurcated into polymerase chain reaction (PCR), next generation sequencing (NGS), immunoassay, and others
  •   Based on indication, the market is bifurcated into cancer, infectious diseases, autoimmune disorders, cardiovascular disorders, and others
  •   Based on application, the market is bifurcated into drug discovery, diagnostics, and personalized medicine

MARKET DYNAMICS
Drivers:

  •   Rising healthcare expenditure
  •   Growing number of Clinical Research Organization (CROs)
  •   Low cost of clinical trials in developing economies

Restraints

  •   High capital investments and low cost-benefit ratio

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The biomarker technologies market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the biomarker technologies market in these regions.

IMPACT OF COVID-19 ON BIOMARKER TECHNOLOGIES MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS

The report covers key developments in the biomarker technologies market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from biomarker technologies market are anticipated to lucrative growth opportunities in the future with the rising demand for biomarker technologies in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the biomarker technologies market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Illumina, Inc.
  •   Agilent Technologies, Inc.
  •   Shimadzu Corporation
  •   Thermo Fisher Scientific, Inc.
  •   F. Hoffmann-La Roche AG
  •   Bio-Rad Laboratories, Inc.
  •   QIAGEN
  •   Merck KGaA
  •   Waters Corporation
  •   Danaher Corporation

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Biomarker Technologies Market - By Product
1.3.2 Biomarker Technologies Market - By Technology
1.3.3 Biomarker Technologies Market - By Indication
1.3.4 Biomarker Technologies Market - By Application
1.3.5 Biomarker Technologies Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BIOMARKER TECHNOLOGIES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BIOMARKER TECHNOLOGIES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BIOMARKER TECHNOLOGIES MARKET - GLOBAL MARKET ANALYSIS
6.1. BIOMARKER TECHNOLOGIES - GLOBAL MARKET OVERVIEW
6.2. BIOMARKER TECHNOLOGIES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. BIOMARKER TECHNOLOGIES MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. INSTRUMENTS
7.3.1. Overview
7.3.2. Instruments Market Forecast and Analysis
7.4. ASSAY AND REAGENTS
7.4.1. Overview
7.4.2. Assay and Reagents Market Forecast and Analysis
7.5. CONSUMABLES
7.5.1. Overview
7.5.2. Consumables Market Forecast and Analysis
8. BIOMARKER TECHNOLOGIES MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. POLYMERASE CHAIN REACTION (PCR)
8.3.1. Overview
8.3.2. Polymerase Chain Reaction (PCR) Market Forecast and Analysis
8.4. NEXT GENERATION SEQUENCING (NGS)
8.4.1. Overview
8.4.2. Next Generation Sequencing (NGS) Market Forecast and Analysis
8.5. IMMUNOASSAY
8.5.1. Overview
8.5.2. Immunoassay Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. BIOMARKER TECHNOLOGIES MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
9.1. OVERVIEW
9.2. INDICATION MARKET FORECASTS AND ANALYSIS
9.3. CANCER
9.3.1. Overview
9.3.2. Cancer Market Forecast and Analysis
9.4. INFECTIOUS DISEASES
9.4.1. Overview
9.4.2. Infectious Diseases Market Forecast and Analysis
9.5. AUTOIMMUNE DISORDERS
9.5.1. Overview
9.5.2. Autoimmune Disorders Market Forecast and Analysis
9.6. CARDIOVASCULAR DISORDERS
9.6.1. Overview
9.6.2. Cardiovascular Disorders Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. BIOMARKER TECHNOLOGIES MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
10.1. OVERVIEW
10.2. APPLICATION MARKET FORECASTS AND ANALYSIS
10.3. DRUG DISCOVERY
10.3.1. Overview
10.3.2. Drug Discovery Market Forecast and Analysis
10.4. DIAGNOSTICS
10.4.1. Overview
10.4.2. Diagnostics Market Forecast and Analysis
10.5. PERSONALIZED MEDICINE
10.5.1. Overview
10.5.2. Personalized Medicine Market Forecast and Analysis
11. BIOMARKER TECHNOLOGIES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Biomarker Technologies Market Overview
11.1.2 North America Biomarker Technologies Market Forecasts and Analysis
11.1.3 North America Biomarker Technologies Market Forecasts and Analysis - By Product
11.1.4 North America Biomarker Technologies Market Forecasts and Analysis - By Technology
11.1.5 North America Biomarker Technologies Market Forecasts and Analysis - By Indication
11.1.6 North America Biomarker Technologies Market Forecasts and Analysis - By Application
11.1.7 North America Biomarker Technologies Market Forecasts and Analysis - By Countries
11.1.7.1 United States Biomarker Technologies Market
11.1.7.1.1 United States Biomarker Technologies Market by Product
11.1.7.1.2 United States Biomarker Technologies Market by Technology
11.1.7.1.3 United States Biomarker Technologies Market by Indication
11.1.7.1.4 United States Biomarker Technologies Market by Application
11.1.7.2 Canada Biomarker Technologies Market
11.1.7.2.1 Canada Biomarker Technologies Market by Product
11.1.7.2.2 Canada Biomarker Technologies Market by Technology
11.1.7.2.3 Canada Biomarker Technologies Market by Indication
11.1.7.2.4 Canada Biomarker Technologies Market by Application
11.1.7.3 Mexico Biomarker Technologies Market
11.1.7.3.1 Mexico Biomarker Technologies Market by Product
11.1.7.3.2 Mexico Biomarker Technologies Market by Technology
11.1.7.3.3 Mexico Biomarker Technologies Market by Indication
11.1.7.3.4 Mexico Biomarker Technologies Market by Application
11.2. EUROPE
11.2.1 Europe Biomarker Technologies Market Overview
11.2.2 Europe Biomarker Technologies Market Forecasts and Analysis
11.2.3 Europe Biomarker Technologies Market Forecasts and Analysis - By Product
11.2.4 Europe Biomarker Technologies Market Forecasts and Analysis - By Technology
11.2.5 Europe Biomarker Technologies Market Forecasts and Analysis - By Indication
11.2.6 Europe Biomarker Technologies Market Forecasts and Analysis - By Application
11.2.7 Europe Biomarker Technologies Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Biomarker Technologies Market
11.2.7.1.1 Germany Biomarker Technologies Market by Product
11.2.7.1.2 Germany Biomarker Technologies Market by Technology
11.2.7.1.3 Germany Biomarker Technologies Market by Indication
11.2.7.1.4 Germany Biomarker Technologies Market by Application
11.2.7.2 France Biomarker Technologies Market
11.2.7.2.1 France Biomarker Technologies Market by Product
11.2.7.2.2 France Biomarker Technologies Market by Technology
11.2.7.2.3 France Biomarker Technologies Market by Indication
11.2.7.2.4 France Biomarker Technologies Market by Application
11.2.7.3 Italy Biomarker Technologies Market
11.2.7.3.1 Italy Biomarker Technologies Market by Product
11.2.7.3.2 Italy Biomarker Technologies Market by Technology
11.2.7.3.3 Italy Biomarker Technologies Market by Indication
11.2.7.3.4 Italy Biomarker Technologies Market by Application
11.2.7.4 Spain Biomarker Technologies Market
11.2.7.4.1 Spain Biomarker Technologies Market by Product
11.2.7.4.2 Spain Biomarker Technologies Market by Technology
11.2.7.4.3 Spain Biomarker Technologies Market by Indication
11.2.7.4.4 Spain Biomarker Technologies Market by Application
11.2.7.5 United Kingdom Biomarker Technologies Market
11.2.7.5.1 United Kingdom Biomarker Technologies Market by Product
11.2.7.5.2 United Kingdom Biomarker Technologies Market by Technology
11.2.7.5.3 United Kingdom Biomarker Technologies Market by Indication
11.2.7.5.4 United Kingdom Biomarker Technologies Market by Application
11.2.7.6 Rest of Europe Biomarker Technologies Market
11.2.7.6.1 Rest of Europe Biomarker Technologies Market by Product
11.2.7.6.2 Rest of Europe Biomarker Technologies Market by Technology
11.2.7.6.3 Rest of Europe Biomarker Technologies Market by Indication
11.2.7.6.4 Rest of Europe Biomarker Technologies Market by Application
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Biomarker Technologies Market Overview
11.3.2 Asia-Pacific Biomarker Technologies Market Forecasts and Analysis
11.3.3 Asia-Pacific Biomarker Technologies Market Forecasts and Analysis - By Product
11.3.4 Asia-Pacific Biomarker Technologies Market Forecasts and Analysis - By Technology
11.3.5 Asia-Pacific Biomarker Technologies Market Forecasts and Analysis - By Indication
11.3.6 Asia-Pacific Biomarker Technologies Market Forecasts and Analysis - By Application
11.3.7 Asia-Pacific Biomarker Technologies Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Biomarker Technologies Market
11.3.7.1.1 Australia Biomarker Technologies Market by Product
11.3.7.1.2 Australia Biomarker Technologies Market by Technology
11.3.7.1.3 Australia Biomarker Technologies Market by Indication
11.3.7.1.4 Australia Biomarker Technologies Market by Application
11.3.7.2 China Biomarker Technologies Market
11.3.7.2.1 China Biomarker Technologies Market by Product
11.3.7.2.2 China Biomarker Technologies Market by Technology
11.3.7.2.3 China Biomarker Technologies Market by Indication
11.3.7.2.4 China Biomarker Technologies Market by Application
11.3.7.3 India Biomarker Technologies Market
11.3.7.3.1 India Biomarker Technologies Market by Product
11.3.7.3.2 India Biomarker Technologies Market by Technology
11.3.7.3.3 India Biomarker Technologies Market by Indication
11.3.7.3.4 India Biomarker Technologies Market by Application
11.3.7.4 Japan Biomarker Technologies Market
11.3.7.4.1 Japan Biomarker Technologies Market by Product
11.3.7.4.2 Japan Biomarker Technologies Market by Technology
11.3.7.4.3 Japan Biomarker Technologies Market by Indication
11.3.7.4.4 Japan Biomarker Technologies Market by Application
11.3.7.5 South Korea Biomarker Technologies Market
11.3.7.5.1 South Korea Biomarker Technologies Market by Product
11.3.7.5.2 South Korea Biomarker Technologies Market by Technology
11.3.7.5.3 South Korea Biomarker Technologies Market by Indication
11.3.7.5.4 South Korea Biomarker Technologies Market by Application
11.3.7.6 Rest of Asia-Pacific Biomarker Technologies Market
11.3.7.6.1 Rest of Asia-Pacific Biomarker Technologies Market by Product
11.3.7.6.2 Rest of Asia-Pacific Biomarker Technologies Market by Technology
11.3.7.6.3 Rest of Asia-Pacific Biomarker Technologies Market by Indication
11.3.7.6.4 Rest of Asia-Pacific Biomarker Technologies Market by Application
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Biomarker Technologies Market Overview
11.4.2 Middle East and Africa Biomarker Technologies Market Forecasts and Analysis
11.4.3 Middle East and Africa Biomarker Technologies Market Forecasts and Analysis - By Product
11.4.4 Middle East and Africa Biomarker Technologies Market Forecasts and Analysis - By Technology
11.4.5 Middle East and Africa Biomarker Technologies Market Forecasts and Analysis - By Indication
11.4.6 Middle East and Africa Biomarker Technologies Market Forecasts and Analysis - By Application
11.4.7 Middle East and Africa Biomarker Technologies Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Biomarker Technologies Market
11.4.7.1.1 South Africa Biomarker Technologies Market by Product
11.4.7.1.2 South Africa Biomarker Technologies Market by Technology
11.4.7.1.3 South Africa Biomarker Technologies Market by Indication
11.4.7.1.4 South Africa Biomarker Technologies Market by Application
11.4.7.2 Saudi Arabia Biomarker Technologies Market
11.4.7.2.1 Saudi Arabia Biomarker Technologies Market by Product
11.4.7.2.2 Saudi Arabia Biomarker Technologies Market by Technology
11.4.7.2.3 Saudi Arabia Biomarker Technologies Market by Indication
11.4.7.2.4 Saudi Arabia Biomarker Technologies Market by Application
11.4.7.3 U.A.E Biomarker Technologies Market
11.4.7.3.1 U.A.E Biomarker Technologies Market by Product
11.4.7.3.2 U.A.E Biomarker Technologies Market by Technology
11.4.7.3.3 U.A.E Biomarker Technologies Market by Indication
11.4.7.3.4 U.A.E Biomarker Technologies Market by Application
11.4.7.4 Rest of Middle East and Africa Biomarker Technologies Market
11.4.7.4.1 Rest of Middle East and Africa Biomarker Technologies Market by Product
11.4.7.4.2 Rest of Middle East and Africa Biomarker Technologies Market by Technology
11.4.7.4.3 Rest of Middle East and Africa Biomarker Technologies Market by Indication
11.4.7.4.4 Rest of Middle East and Africa Biomarker Technologies Market by Application
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Biomarker Technologies Market Overview
11.5.2 South and Central America Biomarker Technologies Market Forecasts and Analysis
11.5.3 South and Central America Biomarker Technologies Market Forecasts and Analysis - By Product
11.5.4 South and Central America Biomarker Technologies Market Forecasts and Analysis - By Technology
11.5.5 South and Central America Biomarker Technologies Market Forecasts and Analysis - By Indication
11.5.6 South and Central America Biomarker Technologies Market Forecasts and Analysis - By Application
11.5.7 South and Central America Biomarker Technologies Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Biomarker Technologies Market
11.5.7.1.1 Brazil Biomarker Technologies Market by Product
11.5.7.1.2 Brazil Biomarker Technologies Market by Technology
11.5.7.1.3 Brazil Biomarker Technologies Market by Indication
11.5.7.1.4 Brazil Biomarker Technologies Market by Application
11.5.7.2 Argentina Biomarker Technologies Market
11.5.7.2.1 Argentina Biomarker Technologies Market by Product
11.5.7.2.2 Argentina Biomarker Technologies Market by Technology
11.5.7.2.3 Argentina Biomarker Technologies Market by Indication
11.5.7.2.4 Argentina Biomarker Technologies Market by Application
11.5.7.3 Rest of South and Central America Biomarker Technologies Market
11.5.7.3.1 Rest of South and Central America Biomarker Technologies Market by Product
11.5.7.3.2 Rest of South and Central America Biomarker Technologies Market by Technology
11.5.7.3.3 Rest of South and Central America Biomarker Technologies Market by Indication
11.5.7.3.4 Rest of South and Central America Biomarker Technologies Market by Application
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BIOMARKER TECHNOLOGIES MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. BIOMARKER TECHNOLOGIES MARKET, KEY COMPANY PROFILES
14.1. ILLUMINA, INC.
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. AGILENT TECHNOLOGIES, INC.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. SHIMADZU CORPORATION
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. THERMO FISHER SCIENTIFIC, INC.
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. F. HOFFMANN-LA ROCHE AG
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. BIO-RAD LABORATORIES, INC
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. QIAGEN
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. MERCK KGAA
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. WATERS CORPORATION
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. DANAHER CORPORATION
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies

1. Illumina, Inc.
2. Agilent Technologies, Inc.
3. Shimadzu Corporation
4. Thermo Fisher Scientific, Inc.
5. F. Hoffmann-La Roche AG
6. Bio-Rad Laboratories, Inc.
7. QIAGEN
8. Merck KGaA
9. Waters Corporation
10. Danaher Corporation
11. PerkinElmer Inc.
12. LI-COR, Inc.
13. General Electric Company
14. BioMerieux SA
15. Biomarker Technologies
16. Myriad Genetics, Inc.
17. Sysmex Corporation
18. Quest Diagnostics Incorporated
19. Siemens
20. Abbott Laboratories
TIPRE00003070
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking